Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 372Neoplasms 325Neoplasm Metastasis 290Leukemia, Myeloid, Acute 282Breast Neoplasms 275Colorectal Neoplasms 235Melanoma 197Ovarian Neoplasms 192Recurrence 185Multiple Myeloma 179Prostatic Neoplasms 157Pancreatic Neoplasms 157Lung Neoplasms 157Squamous Cell Carcinoma of Head and Neck 150Lymphoma, Non-Hodgkin 146Glioblastoma 145Triple Negative Breast Neoplasms 119Myelodysplastic Syndromes 117Carcinoma, Renal Cell 112Stomach Neoplasms 110Advanced Solid Tumors 108Glioma 106Precursor Cell Lymphoblastic Leukemia-Lymphoma 105Lymphoma 104Brain Neoplasms 103Lymphoma, Large B-Cell, Diffuse 102Lymphoma, B-Cell 99Carcinoma, Hepatocellular 95Endometrial Neoplasms 93Lymphoma, Follicular 90

Interventions

rocakinogene sifuplasmid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Hepatitis C × 1 year × Clear all
NCT02772003 2026-04-13

DNA Vaccine Therapy in Treating Patients With Chronic Hepatitis C Virus Infection

National Cancer Institute (NCI)

Phase 1 Active not recruiting
33 enrolled
Gastrointestinal

Hepatitis, Chronic, Hepatitis C, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡